Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

NCT06501989 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Principal Investigator has left Inova

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Biweekly 5-FLUOROURACIL (5-FU)
DRUG: Biweekly Modified FOLFOX6
DRUG: Biweekly FOLFIRI
DRUG: mFOLFOXIRI

Sponsor

Inova Health Care Services